Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $19.45 billion. The enterprise value is $14.83 billion.
Important Dates
The next confirmed earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 199.01 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 199.01M |
| Shares Outstanding | 199.01M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +1.01% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 87.67% |
| Float | 166.62M |
Valuation Ratios
The trailing PE ratio is 13.56 and the forward PE ratio is 12.24. Incyte's PEG ratio is 0.20.
| PE Ratio | 13.56 |
| Forward PE | 12.24 |
| PS Ratio | 3.51 |
| Forward PS | 3.31 |
| PB Ratio | 3.39 |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.20 |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 10.36 |
| EV / Sales | 2.77 |
| EV / EBITDA | 9.58 |
| EV / EBIT | 10.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.72 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | 622.13 |
Financial Efficiency
Return on equity (ROE) is 30.82% and return on invested capital (ROIC) is 71.50%.
| Return on Equity (ROE) | 30.82% |
| Return on Assets (ROA) | 13.89% |
| Return on Invested Capital (ROIC) | 71.50% |
| Return on Capital Employed (ROCE) | 25.21% |
| Weighted Average Cost of Capital (WACC) | 8.96% |
| Revenue Per Employee | $1.89M |
| Profits Per Employee | $503,438 |
| Employee Count | 2,844 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 9.60 |
Taxes
In the past 12 months, Incyte has paid $342.08 million in taxes.
| Income Tax | 342.08M |
| Effective Tax Rate | 19.28% |
Stock Price Statistics
The stock price has increased by +65.21% in the last 52 weeks. The beta is 0.86, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +65.21% |
| 50-Day Moving Average | 96.03 |
| 200-Day Moving Average | 93.07 |
| Relative Strength Index (RSI) | 56.13 |
| Average Volume (20 Days) | 1,368,076 |
Short Selling Information
The latest short interest is 11.97 million, so 6.02% of the outstanding shares have been sold short.
| Short Interest | 11.97M |
| Short Previous Month | 11.44M |
| Short % of Shares Out | 6.02% |
| Short % of Float | 7.19% |
| Short Ratio (days to cover) | 7.92 |
Income Statement
In the last 12 months, Incyte had revenue of $5.36 billion and earned $1.43 billion in profits. Earnings per share was $7.06.
| Revenue | 5.36B |
| Gross Profit | 2.91B |
| Operating Income | 1.45B |
| Pretax Income | 1.77B |
| Net Income | 1.43B |
| EBITDA | 1.55B |
| EBIT | 1.45B |
| Earnings Per Share (EPS) | $7.06 |
Full Income Statement Balance Sheet
The company has $4.02 billion in cash and $33.83 million in debt, giving a net cash position of $3.98 billion or $20.01 per share.
| Cash & Cash Equivalents | 4.02B |
| Total Debt | 33.83M |
| Net Cash | 3.98B |
| Net Cash Per Share | $20.01 |
| Equity (Book Value) | 5.62B |
| Book Value Per Share | 28.21 |
| Working Capital | 4.27B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 94.25M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 54.23%, with operating and profit margins of 27.12% and 26.71%.
| Gross Margin | 54.23% |
| Operating Margin | 27.12% |
| Pretax Margin | 33.09% |
| Profit Margin | 26.71% |
| EBITDA Margin | 28.88% |
| EBIT Margin | 27.12% |
| FCF Margin | n/a |